尽管有部分机构出售,但UnitedHealth Group在2026年第三季度超过了利预期,并提高了全年预期. UnitedHealth Group beat earnings estimates in Q3 2026 and raised full-year guidance, despite some institutional selling.

United Health Group于2026年1月27日报告Q3收入强劲, EPS为2.11美元,略高于估计数,收入为1 132.2亿美元,比年增长12.3%。 UnitedHealth Group reported strong Q3 earnings on January 27, 2026, with $2.11 in EPS, slightly above estimates, and $113.22 billion in revenue, a 12.3% year-over-year increase. 该公司将其2026年全年收入指导提高到17.75美元/股。 The company raised its 2026 full-year earnings guidance to $17.75 per share. 尽管包括Kovack顾问公司和Synovus公司在内的一些机构出售,但Y.D.进行了新的投资。 Despite some institutional selling, including by Kovack Advisors and Synovus, new investments were made by Y.D. 更多投资和持久性资产伙伴。 More Investments and Persistent Asset Partners. 该股票在2026年2月20日交易约289.39美元,市场上限为2 621.14亿美元,P/E比率为21.94,贝塔为0.41。 The stock, trading around $289.39 on February 20, 2026, has a market cap of $262.14 billion, a P/E ratio of 21.94, and a beta of 0.41. 分析师保持“机动购买”共识评级,平均价格目标是372.13美元。 Analysts maintain a “Moderate Buy” consensus rating with a $372.13 average price target.